Gene Therapy for X-linked agammaglobulinemia (XLA)

AAV Stealth switch for applications in gene therapy

Start date project: 2020
Involved institutes: LUMC, KNAW
Stage: Preclinical
Status: Ongoing

AAV Stealth switch for applications in gene therapy

Establishment of a clinical grade human iPS cell line

Start project: 2020
Involved institutes: LUMC, NECSTGEN
Stage: Preclinical
Status: Ongoing

Drug discovery tools

Reversibly Immortalizable Cardiomyocytes

Start date project: 2018
Involved institutes: LUMC
Status: Ongoing

Stay up to date with news, inspirations and events.

© Starfish Innovations. All rights reserved.